메뉴 건너뛰기




Volumn 46, Issue 9, 2015, Pages 2555-2561

Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Asian Patients with Nonvalvular Atrial Fibrillation: Meta-Analysis

Author keywords

anticoagulants; atrial fibrillation; hemorrhage; stroke

Indexed keywords

ANTICOAGULANT AGENT; NON VITAMIN K ANTAGONIST; UNCLASSIFIED DRUG; VITAMIN K GROUP;

EID: 84940366520     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.115.009947     Document Type: Article
Times cited : (192)

References (34)
  • 1
    • 34347394385 scopus 로고    scopus 로고
    • Meta-analysis: Antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation
    • Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med. 2007;146:857-867.
    • (2007) Ann Intern Med. , vol.146 , pp. 857-867
    • Hart, R.G.1    Pearce, L.A.2    Aguilar, M.I.3
  • 2
    • 34447333944 scopus 로고    scopus 로고
    • Racial/ethnic differences in the risk of intracranial hemorrhage among patients with atrial fibrillation
    • Shen AY, Yao JF, Brar SS, Jorgensen MB, Chen W. Racial/ethnic differences in the risk of intracranial hemorrhage among patients with atrial fibrillation. J Am Coll Cardiol. 2007;50:309-315. doi: 10.1016/j.jacc.2007.01.098.
    • (2007) J Am Coll Cardiol. , vol.50 , pp. 309-315
    • Shen, A.Y.1    Yao, J.F.2    Brar, S.S.3    Jorgensen, M.B.4    Chen, W.5
  • 3
    • 84896127396 scopus 로고    scopus 로고
    • Use of antithrombotics in atrial fibrillation in Africa, Europe, Asia and South America: Insights from the International RealiseAF Survey
    • Gamra H, Murin J, Chiang CE, Naditch-Brûlé L, Brette S, Steg PG; RealiseAF investigators. Use of antithrombotics in atrial fibrillation in Africa, Europe, Asia and South America: insights from the International RealiseAF Survey. Arch Cardiovasc Dis. 2014;107:77-87. doi: 10.1016/j.acvd.2014.01.001.
    • (2014) Arch Cardiovasc Dis. , vol.107 , pp. 77-87
    • Gamra, H.1    Murin, J.2    Chiang, C.E.3    Naditch-Brûlé, L.4    Brette, S.5    Steg, P.G.6
  • 4
    • 84899708538 scopus 로고    scopus 로고
    • Stroke prevention in atrial fibrillation: An Asian perspective
    • Chiang CE, Wang KL, Lip GY. Stroke prevention in atrial fibrillation: an Asian perspective. Thromb Haemost. 2014;111:789-797. doi: 10.1160/TH13-11-0948.
    • (2014) Thromb Haemost. , vol.111 , pp. 789-797
    • Chiang, C.E.1    Wang, K.L.2    Lip, G.Y.3
  • 5
    • 84899050921 scopus 로고    scopus 로고
    • Variations in cause and management of atrial fibrillation in a prospective registry of 15,400 emergency department patients in 46 countries: The RE-LY Atrial Fibrillation Registry
    • Oldgren J, Healey JS, Ezekowitz M, Commerford P, Avezum A, Pais P, et al; RE-LY Atrial Fibrillation Registry Investigators. Variations in cause and management of atrial fibrillation in a prospective registry of 15,400 emergency department patients in 46 countries: the RE-LY Atrial Fibrillation Registry. Circulation. 2014;129:1568-1576. doi: 10.1161/CIRCULATIONAHA.113.005451.
    • (2014) Circulation. , vol.129 , pp. 1568-1576
    • Oldgren, J.1    Healey, J.S.2    Ezekowitz, M.3    Commerford, P.4    Avezum, A.5    Pais, P.6
  • 6
    • 84908225423 scopus 로고    scopus 로고
    • Impact of non-Vitamin K antagonist oral anticoagulants on intracranial bleeding in Asian patients with non-valvular atrial fibrillation
    • Yasaka M, Lip GY. Impact of non-vitamin k antagonist oral anticoagulants on intracranial bleeding in Asian patients with non-valvular atrial fibrillation. Circ J. 2014;78:2367-2372.
    • (2014) Circ J. , vol.78 , pp. 2367-2372
    • Yasaka, M.1    Lip, G.Y.2
  • 7
    • 70349306707 scopus 로고    scopus 로고
    • Dabigatran versus warfarin in patients with atrial fibrillation
    • Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, et al; RE-LY Steering Committee and Investigators. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009;361:1139-1151. doi: 10.1056/NEJMoa0905561.
    • (2009) N Engl J Med. , vol.361 , pp. 1139-1151
    • Connolly, S.J.1    Ezekowitz, M.D.2    Yusuf, S.3    Eikelboom, J.4    Oldgren, J.5    Parekh, A.6
  • 8
    • 80052592404 scopus 로고    scopus 로고
    • Rivaroxaban versus warfarin in nonvalvular atrial fibrillation
    • Patel MR, Mahaffey KW, Garg J, Pan G, Singer DE, Hacke W, et al; ROCKET AF Investigators. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med. 2011;365:883-891. doi: 10.1056/NEJMoa1009638.
    • (2011) N Engl J Med. , vol.365 , pp. 883-891
    • Patel, M.R.1    Mahaffey, K.W.2    Garg, J.3    Pan, G.4    Singer, D.E.5    Hacke, W.6
  • 9
    • 80052825103 scopus 로고    scopus 로고
    • Apixaban versus warfarin in patients with atrial fibrillation
    • Granger CB, Alexander JH, McMurray JJ, Lopes RD, Hylek EM, Hanna M, et al; ARISTOTLE Committees and Investigators. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2011;365:981-992. doi: 10.1056/NEJMoa1107039.
    • (2011) N Engl J Med. , vol.365 , pp. 981-992
    • Granger, C.B.1    Alexander, J.H.2    McMurray, J.J.3    Lopes, R.D.4    Hylek, E.M.5    Hanna, M.6
  • 11
    • 76249112303 scopus 로고    scopus 로고
    • Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: A systematic review and meta-analysis
    • van Asch CJ, Luitse MJ, Rinkel GJ, van der Tweel I, Algra A, Klijn CJ. Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis. Lancet Neurol. 2010;9:167-176. doi: 10.1016/S1474-4422(09)70340-0.
    • (2010) Lancet Neurol. , vol.9 , pp. 167-176
    • Van Asch, C.J.1    Luitse, M.J.2    Rinkel, G.J.3    Van Der Tweel, I.4    Algra, A.5    Klijn, C.J.6
  • 12
    • 84884632263 scopus 로고    scopus 로고
    • The J-ROCKET AF study: A matter of ethnicity or a matter of weight
    • Delgado-Fernández M. The J-ROCKET AF study: a matter of ethnicity or a matter of weight? Circ J. 2013;77:2636.
    • (2013) Circ J , vol.77 , pp. 2636
    • Delgado-Fernández, M.1
  • 13
    • 84920520491 scopus 로고    scopus 로고
    • Non-Vitamin K antagonist oral anticoagulants (NOACs) for stroke prevention in Asian patients with atrial fibrillation: Time for a reappraisal
    • Lip GY, Wang KL, Chiang CE. Non-vitamin K antagonist oral anticoagulants (NOACs) for stroke prevention in Asian patients with atrial fibrillation: time for a reappraisal. Int J Cardiol. 2015;180:246-254. doi: 10.1016/j.ijcard.2014.11.182.
    • (2015) Int J Cardiol. , vol.180 , pp. 246-254
    • Lip, G.Y.1    Wang, K.L.2    Chiang, C.E.3
  • 14
    • 84875210172 scopus 로고    scopus 로고
    • Atrial fibrillation management in Asia: From the Asian expert forum on atrial fibrillation
    • Chiang CE, Zhang S, Tse HF, Teo WS, Omar R, Sriratanasathavorn C. Atrial fibrillation management in Asia: from the Asian expert forum on atrial fibrillation. Int J Cardiol. 2013;164:21-32. doi: 10.1016/j.ijcard.2011.12.033.
    • (2013) Int J Cardiol. , vol.164 , pp. 21-32
    • Chiang, C.E.1    Zhang, S.2    Tse, H.F.3    Teo, W.S.4    Omar, R.5    Sriratanasathavorn, C.6
  • 16
    • 84899934698 scopus 로고    scopus 로고
    • Intracranial hemorrhage among patients with atrial fibrillation anticoagulated with warfarin or rivaroxaban: The rivaroxaban once daily, oral, direct factor Xa inhibition compared with Vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation
    • Hankey GJ, Stevens SR, Piccini JP, Lokhnygina Y, Mahaffey KW, Halperin JL, et al; ROCKET AF Steering Committee and Investigators. Intracranial hemorrhage among patients with atrial fibrillation anticoagulated with warfarin or rivaroxaban: the rivaroxaban once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation. Stroke. 2014;45:1304-1312. doi: 10.1161/STROKEAHA.113.004506.
    • (2014) Stroke. , vol.45 , pp. 1304-1312
    • Hankey, G.J.1    Stevens, S.R.2    Piccini, J.P.3    Lokhnygina, Y.4    Mahaffey, K.W.5    Halperin, J.L.6
  • 17
    • 84861616750 scopus 로고    scopus 로고
    • Intracranial hemorrhage in atrial fibrillation patients during anticoagulation with warfarin or dabigatran: The RE-LY trial
    • Hart RG, Diener HC, Yang S, Connolly SJ, Wallentin L, Reilly PA, et al. Intracranial hemorrhage in atrial fibrillation patients during anticoagulation with warfarin or dabigatran: the RE-LY trial. Stroke. 2012;43:1511-1517. doi: 10.1161/STROKEAHA.112.650614.
    • (2012) Stroke. , vol.43 , pp. 1511-1517
    • Hart, R.G.1    Diener, H.C.2    Yang, S.3    Connolly, S.J.4    Wallentin, L.5    Reilly, P.A.6
  • 18
    • 84905259309 scopus 로고    scopus 로고
    • Cerebrovascular events in 21 105 patients with atrial fibrillation randomized to edoxaban versus warfarin: Effective Anticoagulation with Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48
    • Giugliano RP, Ruff CT, Rost NS, Silverman S, Wiviott SD, Lowe C, et al; ENGAGE AF-TIMI 48 Investigators. Cerebrovascular events in 21 105 patients with atrial fibrillation randomized to edoxaban versus warfarin: Effective Anticoagulation with Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48. Stroke. 2014;45:2372-2378. doi: 10.1161/STROKEAHA.114.006025.
    • (2014) Stroke. , vol.45 , pp. 2372-2378
    • Giugliano, R.P.1    Ruff, C.T.2    Rost, N.S.3    Silverman, S.4    Wiviott, S.D.5    Lowe, C.6
  • 19
    • 84922480892 scopus 로고    scopus 로고
    • Eligibility and preference of new oral anticoagulants in patients with atrial fibrillation: Comparison between patients with versus without stroke
    • Yoon CH, Park YK, Kim SJ, Lee MJ, Ryoo S, Kim GM, et al. Eligibility and preference of new oral anticoagulants in patients with atrial fibrillation: comparison between patients with versus without stroke. Stroke. 2014;45:2983-2988. doi: 10.1161/STROKEAHA.114.005599.
    • (2014) Stroke. , vol.45 , pp. 2983-2988
    • Yoon, C.H.1    Park, Y.K.2    Kim, S.J.3    Lee, M.J.4    Ryoo, S.5    Kim, G.M.6
  • 20
    • 84879962384 scopus 로고    scopus 로고
    • Dabigatran versus warfarin: Effects on ischemic and hemorrhagic strokes and bleeding in Asians and non-Asians with atrial fibrillation
    • Hori M, Connolly SJ, Zhu J, Liu LS, Lau CP, Pais P, et al; RE-LY Investigators. Dabigatran versus warfarin: effects on ischemic and hemorrhagic strokes and bleeding in Asians and non-Asians with atrial fibrillation. Stroke. 2013;44:1891-1896. doi: 10.1161/STROKEAHA.113.000990.
    • (2013) Stroke. , vol.44 , pp. 1891-1896
    • Hori, M.1    Connolly, S.J.2    Zhu, J.3    Liu, L.S.4    Lau, C.P.5    Pais, P.6
  • 21
    • 84901924970 scopus 로고    scopus 로고
    • Rivaroxaban for stroke prevention in East Asian patients from the ROCKET AF trial
    • Wong KS, Hu DY, Oomman A, Tan RS, Patel MR, Singer DE, et al; Executive Steering Committee and the ROCKET AF Study Investigators. Rivaroxaban for stroke prevention in East Asian patients from the ROCKET AF trial. Stroke. 2014;45:1739-1747. doi: 10.1161/STROKEAHA.113.002968.
    • (2014) Stroke. , vol.45 , pp. 1739-1747
    • Wong, K.S.1    Hu, D.Y.2    Oomman, A.3    Tan, R.S.4    Patel, M.R.5    Singer, D.E.6
  • 22
    • 84908545649 scopus 로고    scopus 로고
    • Efficacy and safety of apixaban compared with warfarin for stroke prevention in patients with atrial fibrillation from East Asia: A subanalysis of the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial
    • Goto S, Zhu J, Liu L, Oh BH, Wojdyla DM, Aylward P, et al; ARISTOTLE Investigators. Efficacy and safety of apixaban compared with warfarin for stroke prevention in patients with atrial fibrillation from East Asia: a subanalysis of the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial. Am Heart J. 2014;168:303-309. doi: 10.1016/j.ahj.2014.06.005.
    • (2014) Am Heart J. , vol.168 , pp. 303-309
    • Goto, S.1    Zhu, J.2    Liu, L.3    Oh, B.H.4    Wojdyla, D.M.5    Aylward, P.6
  • 24
    • 84865138532 scopus 로고    scopus 로고
    • Indirect comparisons of new oral anticoagulant drugs for efficacy and safety when used for stroke prevention in atrial fibrillation
    • Lip GY, Larsen TB, Skjøth F, Rasmussen LH. Indirect comparisons of new oral anticoagulant drugs for efficacy and safety when used for stroke prevention in atrial fibrillation. J Am Coll Cardiol. 2012;60:738-746. doi: 10.1016/j.jacc.2012.03.019.
    • (2012) J Am Coll Cardiol. , vol.60 , pp. 738-746
    • Lip, G.Y.1    Larsen, T.B.2    Skjøth, F.3    Rasmussen, L.H.4
  • 25
    • 84863981277 scopus 로고    scopus 로고
    • Metaanalysis of efficacy and safety of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus warfarin in patients with atrial fibrillation
    • Miller CS, Grandi SM, Shimony A, Filion KB, Eisenberg MJ. Metaanalysis of efficacy and safety of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus warfarin in patients with atrial fibrillation. Am J Cardiol. 2012;110:453-460. doi: 10.1016/j.amjcard.2012.03.049.
    • (2012) Am J Cardiol. , vol.110 , pp. 453-460
    • Miller, C.S.1    Grandi, S.M.2    Shimony, A.3    Filion, K.B.4    Eisenberg, M.J.5
  • 26
    • 84881477376 scopus 로고    scopus 로고
    • Novel oral anticoagulants versus warfarin in non-valvular atrial fibrillation: A meta-analysis of 50,578 patients
    • Capodanno D, Capranzano P, Giacchi G, Calvi V, Tamburino C. Novel oral anticoagulants versus warfarin in non-valvular atrial fibrillation: a meta-analysis of 50,578 patients. Int J Cardiol. 2013;167:1237-1241. doi: 10.1016/j.ijcard.2012.03.148.
    • (2013) Int J Cardiol. , vol.167 , pp. 1237-1241
    • Capodanno, D.1    Capranzano, P.2    Giacchi, G.3    Calvi, V.4    Tamburino, C.5
  • 27
    • 84896117299 scopus 로고    scopus 로고
    • Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: A metaanalysis of randomised trials
    • Ruff CT, Giugliano RP, Braunwald E, Hoffman EB, Deenadayalu N, Ezekowitz MD, et al. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a metaanalysis of randomised trials. Lancet. 2014;383:955-962. doi: 10.1016/S0140-6736(13)62343-0.
    • (2014) Lancet. , vol.383 , pp. 955-962
    • Ruff, C.T.1    Giugliano, R.P.2    Braunwald, E.3    Hoffman, E.B.4    Deenadayalu, N.5    Ezekowitz, M.D.6
  • 28
    • 84880785759 scopus 로고    scopus 로고
    • Gastrointestinal bleeding with the new oral anticoagulants-defining the issues and the management strategies
    • Desai J, Kolb JM, Weitz JI, Aisenberg J. Gastrointestinal bleeding with the new oral anticoagulants-defining the issues and the management strategies. Thromb Haemost. 2013;110:205-212. doi: 10.1160/TH13-02-0150.
    • (2013) Thromb Haemost. , vol.110 , pp. 205-212
    • Desai, J.1    Kolb, J.M.2    Weitz, J.I.3    Aisenberg, J.4
  • 29
    • 84900992940 scopus 로고    scopus 로고
    • Major bleeding in patients with atrial fibrillation receiving apixaban or warfarin: The ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation): Predictors, characteristics, and clinical outcomes
    • Hylek EM, Held C, Alexander JH, Lopes RD, De Caterina R, Wojdyla DM, et al. Major bleeding in patients with atrial fibrillation receiving apixaban or warfarin: The ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation): predictors, characteristics, and clinical outcomes. J Am Coll Cardiol. 2014;63:2141-2147. doi: 10.1016/j.jacc.2014.02.549.
    • (2014) J Am Coll Cardiol. , vol.63 , pp. 2141-2147
    • Hylek, E.M.1    Held, C.2    Alexander, J.H.3    Lopes, R.D.4    De Caterina, R.5    Wojdyla, D.M.6
  • 30
    • 84873569160 scopus 로고    scopus 로고
    • Concomitant use of antiplatelet therapy with dabigatran or warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial
    • Dans AL, Connolly SJ, Wallentin L, Yang S, Nakamya J, Brueckmann M, et al. Concomitant use of antiplatelet therapy with dabigatran or warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial. Circulation. 2013;127:634-640. doi: 10.1161/CIRCULATIONAHA.112.115386.
    • (2013) Circulation. , vol.127 , pp. 634-640
    • Dans, A.L.1    Connolly, S.J.2    Wallentin, L.3    Yang, S.4    Nakamya, J.5    Brueckmann, M.6
  • 31
    • 84890427300 scopus 로고    scopus 로고
    • Apixaban vs. Warfarin with concomitant aspirin in patients with atrial fibrillation: Insights from the ARISTOTLE trial
    • Alexander JH, Lopes RD, Thomas L, Alings M, Atar D, Aylward P, et al. Apixaban vs. warfarin with concomitant aspirin in patients with atrial fibrillation: insights from the ARISTOTLE trial. Eur Heart J. 2014;35:224-232. doi: 10.1093/eurheartj/eht445.
    • (2014) Eur Heart J. , vol.35 , pp. 224-232
    • Alexander, J.H.1    Lopes, R.D.2    Thomas, L.3    Alings, M.4    Atar, D.5    Aylward, P.6
  • 32
    • 84934298609 scopus 로고    scopus 로고
    • Genetics and the clinical response to warfarin and edoxaban: Findings from the randomised, double-blind ENGAGE AF-TIMI 48 trial
    • Mega JL, Walker JR, Ruff CT, Vandell AG, Nordio F, Deenadayalu N, et al. Genetics and the clinical response to warfarin and edoxaban: findings from the randomised, double-blind ENGAGE AF-TIMI 48 trial. Lancet. 2015;385:2280-2287. doi: 10.1016/S0140-6736(14)61994-2.
    • (2015) Lancet. , vol.385 , pp. 2280-2287
    • Mega, J.L.1    Walker, J.R.2    Ruff, C.T.3    Vandell, A.G.4    Nordio, F.5    Deenadayalu, N.6
  • 33
    • 31344451857 scopus 로고    scopus 로고
    • Different contributions of polymorphisms in VKORC1 and CYP2C9 to intra-and inter-population differences in maintenance dose of warfarin in Japanese, Caucasians and African-Americans
    • Takahashi H, Wilkinson GR, Nutescu EA, Morita T, Ritchie MD, Scordo MG, et al. Different contributions of polymorphisms in VKORC1 and CYP2C9 to intra-and inter-population differences in maintenance dose of warfarin in Japanese, Caucasians and African-Americans. Pharmacogenet Genomics. 2006;16:101-110.
    • (2006) Pharmacogenet Genomics. , vol.16 , pp. 101-110
    • Takahashi, H.1    Wilkinson, G.R.2    Nutescu, E.A.3    Morita, T.4    Ritchie, M.D.5    Scordo, M.G.6
  • 34
    • 85027920679 scopus 로고    scopus 로고
    • VKORC1 and CYP2C9 genotype distribution in Asian countries
    • Gaikwad T, Ghosh K, Shetty S. VKORC1 and CYP2C9 genotype distribution in Asian countries. Thromb Res. 2014;134:537-544. doi: 10.1016/j.thromres.2014.05.028.
    • (2014) Thromb Res. , vol.134 , pp. 537-544
    • Gaikwad, T.1    Ghosh, K.2    Shetty, S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.